TSANZ home

Results for "Application form"

Home 5 Search query for: Application form
Results for "Application form"
VOLUME 6.03 – MARCH 2021

VOLUME 6.03 – MARCH 2021

Research Roundup:

March 2021

Welcome Message

We hope you’ve been keeping safe and well.

The TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship is now open. This award aims to facilitate the establishment of mid-career invenstigators as independent, self-directed researchers and to foster the development of high-quality respiratory research in Australia and New Zealand.

Please note that the TSANZ Indigenous Respiratory Nursing Award will be closing 12 April 2021 and the Boehringer Ingelheim New Zealand Primary Care Award will be closing 05 April 2021.

 

Don’t forget to register for our first ever Virtual Annual Scientific Meeting – TSANZSRS21.

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the March edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Indigenous Respiratory Nursing Award – extended – closing 12 April 2021

Boehringer Ingelheim New Zealand Primary Care Award – closing 05 April 2021

TSANZ and National Asthma Council Australia Asthma and Airways Career Development Fellowship – closing 31 May 2021

  

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

2021 Australian Museum Eureka Prizes

Do you know someone making a difference in their field?

Entries to the 2021 Australian Museum Eureka Prizes are now open!

This year, there are 16 prizes on offer that cover a broad spectrum of scientific disciplines, which aim to recognise the achievements of scientists, researchers, and science communicators at all career stages.

There are prizes available for both individuals and teams, and entrants can either enter themselves or be nominated. The Eureka Prizes are open, but not limited to, those who work in research institutes, government departments, media, corporations, and universities. It’s free to enter and there’s a prize pool of $160,000 to be shared between the winners.

If you know an individual or team doing outstanding work, why not encourage them to enter?

Entries close 7pm AEST Friday 28 May

VIEW THE FULL PRIZE PROGRAM

Registrations open for ASM

Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

Respirology – Editor’s Choice

Respirology Issue 26.3 March 2021

The impact of regular bisoprolol on the response to salbutamol in asthma: A double-blind randomized placebo-controlled crossover trial

Miriam R. Bennett, Catherina L. Chang, Chris Tuffery, Sandra Hopping and Robert J. Hancox

DOI: 10.1111/resp.13955

Outcomes of protracted bacterial bronchitis in children: A 5-year prospective cohort study

Tom J.C. Ruffles, Julie M. Marchant, Ian B. Masters, Stephanie T. Yerkovich, Danielle F. Wurzel, Peter G. Gibson, Greta Busch, Katherine J. Baines, Jodie L. Simpson, Heidi C. Smith-Vaughan, Susan J. Pizzutto, Helen M. Buntain, Gregory Hodge, Sandra Hodge, John W. Upham and Anne B. Chang

DOI: 10.1111/resp.13950

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about the most effective treatments and combinations of treatments for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand, Indian and Denmark. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

The global response to COVID-19 is working to accelerate diagnostics, vaccines and therapeutics. While remdesivir has been shown to accelerate time to recovery, and low-dose dexamethasone to decrease mortality, more effective therapies are needed.

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

ASCOT ADAPT includes 3 treatment domains:

Domain A (Antiviral)

  1. Standard of care
  2. Standard of care + nafamostat

Domain B (Antibody)

  1. Standard of care
  2. Standard of care + convalescent plasma

Domain C (Anticoagulation)

  1. Standard dose thromboprophylaxis
  2. Intermediate dose thromboprophylaxis
  3. Standard dose thromboprophylaxis plus aspirin

Eligible patients can be randomised to one or more domains concurrently.

Protocol documents and further details are available at www.ascot-trial.edu.au

 Australasian Society for Medical Research message

The Thoracic Society is an affiliate member of the ASMR. Please see below for their latest communications.

Dear ASMR member

The Australian National Audit Office has informed us that an audit of ‘Health’s Management of the Medical Research Future Fund’ is currently open for contribution. The period for submissions is expected to close on 30 May 2021 and the audit report will be tabled in September 2021.

“The objective of this audit is to assess whether the Department of Health is effectively managing the Medical Research Future Fund (MRFF)” with respect to the following criteria:

  • “Are the MRFF governance arrangements effective?”
  • “Has MRFF legislation, governance, strategies and priorities guided selection of medical research initiatives?”
  • “Does Health effectively monitor, measure and evaluate MRFF’s performance?”

Submissions are confidential and can be anonymous (name, address and contact number fields provided are not required for a submission) so I encourage you and your extended networks to contribute instances or evidence around issues relating to the audit criteria for an ASMR submission (please send to president@asmr.org.au), or if you prefer, make a submission directly to the audit webpage.

While the addition of the MRFF to the health and medical research funding landscape is greatly welcomed, since its inception in 2014, Australian clinicians and researchers have expressed concerns about the MRFF processes and governance. I therefore cannot stress the importance of providing accurate, appropriate and verifiable submissions to the auditors with regard to the audit objective and criteria.

 

Yours sincerely,
Dr Ryan Davis
ASMR President 2021

Surveys and Research

SURVEY OF LUNG CANCER CARE IN AUSTRALIA

We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

  • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
  • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
  • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

Thank you for your time.

Prof Fraser Brims
Curtin Medical School
fraser.brims@curtin.edu.au 

TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

This study has now been completed and below is a summary of the findings from this work.

The top 3 priorities rank by people with PF and caregivers were:

  1. What medications can reverse scarring in the lungs of people with PF?
  2. What medications can improve lung function in people with PF?
  3. What are the causes of PF?

The top 3 priorities rank by people with healthcare professionals/researchers were:

  1. What medications can reverse scarring in the lungs of people with PF?
  2. How can we prevent PF?
  3. What are the causes of PF?

The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

(click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

Yours sincerely,

Anne Holland
Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

VOLUME 6.03 – MARCH 2021

VOLUME 6.02 – FEBRUARY 2021

Research Roundup:

February 2021

Welcome Message

We hope you’ve been keeping safe and well.

We are pleased to announce that the Boehringer Ingelheim New Zealand Primary Care Grant is now open. This grant aims to support research in respiratory health within the primary care sphere in New Zealand. Primary care can include general practice, allied health services, nursing in community health and community pharmacy.

Please note that a number of awards are closing this Wednesday 24 February. These include our modified travel awards that take into account travel bans and restrictions.

Don’t forget to register for our first ever Virtual Annual Scientific Meeting – TSANZSRS21.

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the February edition of your Research Roundup.

Prof Sandra Hodge
Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Indigenous Respiratory Nursing Award – closing 01 April 2021

Boehringer Ingelheim New Zealand Primary Care Award – closing 05 April 2021

TSANZ National Asthma Council Australia – Asthma & Airways Fellowship – closing 31 May 2021

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Grifols Scientific Awards

The 18th Annual ALTA Alpha-1-Antitrypsin Laurell’s Training Award is now open.

Deadline for submission of letter of intent – 1 March 2021

Deadline for submission of full proposal – 31 May 2021

Registrations open for ASM

Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

Respirology – Editor’s Choice

Respirology Issue 26.2 February 2021

Effects of roflumilast on arterial stiffness in COPD (ELASTIC): A randomized trial

Matthias H. Urban, Nicole Kreibich, Andreas Gleiss, Georg-Christian Funk, Sylvia Hartl and Otto C. Burghuber

DOI: 10.1111/resp.13914

 ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about the most effective treatments and combinations of treatments for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand, Indian and Denmark. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

The global response to COVID-19 is working to accelerate diagnostics, vaccines and therapeutics. While remdesivir has been shown to accelerate time to recovery, and low-dose dexamethasone to decrease mortality, more effective therapies are needed.

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

ASCOT ADAPT includes 3 treatment domains:

Domain A (Antiviral)

  1. Standard of care
  2. Standard of care + nafamostat

Domain B (Antibody)

  1. Standard of care
  2. Standard of care + convalescent plasma

Domain C (Anticoagulation)

  1. Standard dose thromboprophylaxis
  2. Intermediate dose thromboprophylaxis
  3. Standard dose thromboprophylaxis plus aspirin

Eligible patients can be randomised to one or more domains concurrently.

Protocol documents and further details are available at www.ascot-trial.edu.au

Surveys and Research

SURVEY OF LUNG CANCER CARE IN AUSTRALIA

We would be grateful please for less than 5 minutes of your time to complete this survey which is designed to provide a snapshot of the current status of lung cancer care and MDTs around Australia.

  • These data will help inform vital services planning for lung cancer care and will directly inform ongoing discussions with Government about lung cancer care across Australia.
  • We are only asking for one response from each institution, we suggest it is the lead clinician for the lung cancer MDT.
  • Curtin University Human Research Ethics Committee (HREC) has approved this study (HREC number HRE2021-0031).

Please follow the link to the Australian-wide Survey of Lung Cancer Care, or use the QR code below.

Thank you for your time.

Prof Fraser Brims
Curtin Medical School
fraser.brims@curtin.edu.au 

TOP 10 RESEARCH PRIORITIES FOR PULMONARY FIBROSIS

A recent research study as part of the NHMRC’s Centre of Research Excellence in Pulmonary Fibrosis grant aimed to identify the top 10 research priorities for pulmonary fibrosis (PF) according to people living with pulmonary fibrosis, caregivers, health professionals and researchers.

This study has now been completed and below is a summary of the findings from this work.

The top 3 priorities rank by people with PF and caregivers were:

  1. What medications can reverse scarring in the lungs of people with PF?
  2. What medications can improve lung function in people with PF?
  3. What are the causes of PF?

The top 3 priorities rank by people with healthcare professionals/researchers were:

  1. What medications can reverse scarring in the lungs of people with PF?
  2. How can we prevent PF?
  3. What are the causes of PF?

The findings from this study have been published in a peer-reviewed journal and will help guide future research directions.

(click on the link to view the paper– https://doi.org/10.1136/thoraxjnl-2020-215731)

The Study team extends their thanks and appreciation to all those who participated in the study for their time and valuable contribution to this work.

Yours sincerely,

Anne Holland
Professor of Physiotherapy (Research), Monash University (anne.holland@monash.edu)

TBPod

The TBPod are podcasts designed for clinicians and policymakers with an interest tuberculosis. These podcasts consist of conversations with expert clinicians, researchers, policy makers and advocates about their work in the field of tuberculosis. The TBPod is prepared by ACTnet and the TB Forum and can be found on ITunes, Spotify, and the ACTnet Website.

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

VOLUME 6.03 – MARCH 2021

VOLUME 6.01 – JANUARY 2021

Research Roundup:

January 2021

Welcome Message

Welcome to the first edition of our TSANZ Research Roundup for 2021. We hope you’ve kept safe and well over the festive season.

The TSANZ Indigenous Respiratory Nursing Award is now open. This award aims to raise the profile of indigenous health within respiratory nursing and the work of respiratory nurses of an indigenous background.

The TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health has been extended to 24 February 2021. This award, to honour the memory of the late Prof. Rob Pierce, will be awarded to a member of the TSANZ for a project focused on understanding and improving the lung health of Indigenous people in Australia and/or New Zealand.

Our two travel awards, TSANZ Janet Elder International Travel Award and Boehringer Ingelheim New Zealand COPD Travel Award have been extended to 24 February 2021. These awards have been modified to allow for professional development or research support instead of travel should the international scientific meetings not proceed or travel restrictions prevent you from attending.

Don’t forget to take advantage of the earlybird prices for our first ever Virtual Annual Scientific Meeting – TSANZSRS21.

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the January edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

Open Awards

Thoracic Society Awards

TSANZ Janet Elder International Travel Award – extended – closing 24 February 2021

Boehringer Ingelheim New Zealand COPD Travel Award – extended – closing 24 February 2021

TSANZ Peter Phelan Research Grant – closing 27 January 2021

Maurice Blackburn Occupational Lung Disease Grant-in-Aid – closing 27 January 2021

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – extended – closing 24 February 2021

TSANZ Indigenous Respiratory Nursing Award – closing 24 February 2021

Cystic Fibrosis Australia Awards

Australian Cystic Fibrosis Research Trust 2021 Innovation Grant – closing 29 January 2021

Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF)

PACT Grant-in-Aid – closing 14 February 2021

CREATE Grant-in-Aid – closing 14 February 2021

     

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

 

Registrations open for ASM

Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

Register now to take advantage of the earlybird prices. Earlybird registrations will be available until 12 February 2021.

 

Respirology – Editor’s Choice

Respirology Issue 26.1 January 2021

 

Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma–COPD overlap

Sarah A. Hiles, Peter G. Gibson and Vanessa M. McDonald

DOI: 10.1111/resp.13841

 

Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with COPD: A randomized controlled trial

Fanny Wai-San Ko, Wilson Tam, Eddy H.S. Siu, Ka-Pang Chan, Jenny Chun-Li Ngai, So-Shan Ng, Tat On Chan1 and David Shu-Cheong Hui

DOI: 10.1111/resp.13872

 

 ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about the most effective treatments and combinations of treatments for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand, Indian and Denmark. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

The global response to COVID-19 is working to accelerate diagnostics, vaccines and therapeutics. While remdesivir has been shown to accelerate time to recovery, and low-dose dexamethasone to decrease mortality, more effective therapies are needed.

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

ASCOT ADAPT includes 3 treatment domains:

Domain A (Antiviral)

  1. Standard of care
  2. Standard of care + nafamostat

Domain B (Antibody)

  1. Standard of care
  2. Standard of care + convalescent plasma

Domain C (Anticoagulation)

  1. Standard dose thromboprophylaxis
  2. Intermediate dose thromboprophylaxis
  3. Standard dose thromboprophylaxis plus aspirin

Eligible patients can be randomised to one or more domains concurrently.

Protocol documents and further details are available at www.ascot-trial.edu.au

VOLUME 6.03 – MARCH 2021

VOLUME 5.07 – DECEMBER 2020

Research Roundup:

December 2020

Welcome Message

Welcome to this month’s edition of our TSANZ Research Roundup.

This is a busy time for TSANZ and LFA’s research awards, with the Ann Woolcock New Investigator Award and LFA Ludwig Engel Research Award, Lizotte Family Research Award and Ivan Cash Research Awards currently under review. Keep your eyes open for several TSANZ awards opening soon! These will be accessible on the TSANZ Awards Submission Portal and include the new CFA Innovation Grant as detailed below. Also note NHMRC’s Special Initiative in Human Health and Environmental Change (SIHHEC). This will provide a catalytic stimulus to improve Australia’s current capability and capacity in human health and environmental change research, by supporting a single, multidisciplinary, nationally focused, collaborative network of researchers across Australia. The work of this network will help to protect the health of the Australian community and build a resilient and responsive health system. The focus includes improving current understanding of the complex interactions between primary, secondary and tertiary health effects of environmental and climate change.

Plans for our virtual ASM in 2021 are well underway, with registrations now open. Please visit our TSANZSRS2021 website for more details.

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the December edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ Janet Elder International Travel Award – closing 15 January 2021

Boehringer Ingelheim New Zealand COPD Travel Award – closing 15 January 2021

TSANZ Peter Phelan Research Grant – closing 27 January 2021

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closing 27 January 2021

Maurice Blackburn Occupational Lung Disease Grant-in-Aid – closing 27 January 2021

Lung Foundations Awards

Cochrane Airways Australia Scholarship – closing 4 December 2020

Cystic Fibrosis Australia Awards

Australian Cystic Fibrosis Research Trust 2021 Innovation Grant – closing 29 January 2021

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Cystic Fibrosis Innovation Grant

Cystic Fibrosis Australia (CFA) is pleased to announce the 2021 Innovation Grant for post- doctoral researchers, currently working in cystic fibrosis (CF) research. This grant is awarded annually to one applicant for one year.

The Innovation Grant will allow a CF researcher to explore novel concepts at the initial feasibility stage.  Innovative applications relating to any aspect in the field of CF are encouraged, even those lacking pilot data.  The grant aims to allow the researcher to generate sufficient data within the one-year grant period to be in a position to apply for additional support from an appropriate funding body to continue the research.

The Innovation grant will be offered to post-doctoral researchers currently working in or proposing to work in CF research.  The researcher will have completed a research higher degree in CF or a related area within the last ten years.

The recipient of the Innovation Grant is required to provide progress reports on their research to CFA every six months.  In addition, and where appropriate, the recipient will be asked to make a presentation at a CFA conference (held every two years) in Australia.

The maximum amount awarded under the Innovation Grant will be $80,000.  The actual amount provided will be subject to approval of the applicant’s budget.

Applications can be made through the website of The Thoracic Society of Australia & New Zealand (TSANZ) and must be received by TSANZ no later than 5.00 pm (AEDT) 29th January 2021.

Registrations open for ASM

Registrations are now open for our first ever Virtual Annual Scientific Meeting! Be a part of TSANZSRS21 on 1-2 May 2021 from the comfort of your own home.

Respirology – Editor’s Choice

Respirology Issue 25.11 November 2020

 

Predictive value of control of COPD for risk of exacerbations: An international, prospective study

Marc Miravitlles, Pawel Sliwinski, Chin Kook Rhee, Richard W. Costello, Victoria Carter, Jessica H.Y. Tan, Therese S. Lapperre, Bernardino Alcazar, Caroline Gouder, Cristina Esquinas, Juan Luis García-Rivero, Anu Kemppinen, Augustine Tee, Miguel Roman-Rodrígues, Juan José Solder-Cataluña, David B. Price and on behlaf of the Respiratory Effectiveness Group (REG)

 

Cover caption: Control in COPD is a tool to assess clinical patient status and decision making on step-up or down treatment. Uncontrolled status is associated with an increased risk of exacerbations. This is a collaborative international study of REG, a not-for-profit initiative established by international experts in real-life and comparative effectiveness research in respiratory medicine

DOI: 10.1111/resp.13811

 

Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study

Giacomo Sgalla, Erminia Lo Greco, Mariarosaria Calvello, Francesco Varone, Bruno Iovene, Stefania Cerri, Pierluigi Donatelli, Ada Vancheri, Mauro Pavone, Fabrizio Luppi, Carlo Vancheri and Luca Richeldi

 

Cover caption: The collaborative research team from three Italian centres in Catania, Rome and Modena. From left to right: Ada Vancheri, Carlo Vancheri, Bruno Iovene, Mauro Pavone, Giacomo Sgalla, Stefania Cerri, Francesco Varone, Luca Richeldi.

DOI: 10.1111/resp.13805

 

Respirology Issue 25.12 December 2020

 

 

Bronchial thermoplasty versus mepolizumab: Comparison of outcomes in a severe asthma clinic

David Langton, Joy Shia, Suzy Guo, Julie Sharp, Ceri Banks, Wei Wang, Virginia Plumber and Francis Thien

 

Cover caption:

Bronchial thermoplasty: Work in progress

DOI: 10.1111/resp.13830

 

Cost of hospitalisation for bronchiectasis exacerbation in children

Vikas Goyal, Steven M McPhail, Frank Hurley, Keith Grimwood, Julie M Marchant, I Brent Masters and Anne B Chang

 

Cover caption:

The emblem of AusBREATHE (Australian Bronchiectasis Centre of Research Excellence, especially for Aboriginal and Torres Strait Islander Children) is a reproduction of a painting by First Nations artist and former Menzies employee, who describes how the painting represents the lungs as follows:

‘When the earth was made, so were the first trees. They cleaned the air through their branches and leaves. The same is reflected in us with our lungs; they have branches like trees breathing in the air and cleaning our body and provide much needed oxygen.The butterflies represent a delicate balance; if something happens to the air, the butterflies will die. That’s why we must look after our air, like we have to look after our lungs because they keep us alive. The red dots represent alveoli that are at the end of the branches.’

DOI: 10.1111/resp.13828

Research Review

NZ Respiratory Research Review Issue 177

 

NZ Respiratory Research Review Issue 178

NZ Respiratory Research Review Issue 179

As part of an ongoing series focussing on new registrations in Australia, Research Review has released a product review of the use of beclometasone dipropionate/formoterol (Fostair) for patients with asthma.

This review discusses the evidence in support of the use of Fostair, its pharmacological properties, dosage and administration, and efficacy and tolerability as demonstrated in pivotal clinical trials. It also provides commentary and recommendations from Professor Francis Thien, Director of the Department of Respiratory and Sleep Medicine at Box Hill Hospital, Eastern Health, and the Monash University Clinical School in Melbourne, Australia.

 

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ.

 

VOLUME 6.03 – MARCH 2021

VOLUME 5.06 – SEPTEMBER 2020

Research Roundup:

September 2020

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. We hope that you remain well during this difficult time, and our thoughts are especially with our Victorian members who are on the front-line treating patients with COVID or facing unprecedented restrictions.

Plans for our exciting first virtual ASM in 2021 are well underway, with abstract submissions opened on 21 September 2020 and registrations opening on 22 October 2020. Please visit our TSANZSRS2021 website for more details about abstracts, and pay close attention to the closing date of 6 November 2020. Abstracts submitted to the 2020 Annual Scientific Meeting are eligible to be resubmitted for the 2021 Annual Scientific Meeting, and all resubmitted abstracts will undergo the same robust peer review process for allocation to oral or poster sessions.

The TSANZ Webinar Series continue, with the Society Medal and 50th Anniversary Medalpresentations on 30 September, so don’t forget to register for these exciting events.  

Please also note the opening of the following awards that are now accessible on the TSANZ Awards Submission Portal:

  • Past Presidents Scholarship Award: this new award will support national or international travel costs to present research for early career researchers who do not have the resources available to them via their institution or workplace. Importantly, the awardee will have the support from a TSANZ Past President who will provide invaluable feedback and professional development guidance to help them develop their research presentation skills.
  • Boehringer Ingelheim New Zealand Primary Care Grant: this award addresses the issue of access to primary care in New Zealand, particularly during restrictions like those faced during the COVID-19 pandemic.

In addition, we are pleased to announce the new CREATE PhD Scholarship, and the opening of LFA Awards:

Finally, please consider helping us to provide essential funding for our world class respiratory researchers and for our TSANZ awards. You can leave a tax deductible donation of your choice in our areas of need, whether it be a donation to our Benevolent Fund or to support research, establishing a named award or leaving TSANZ a gift in your will. Details can be found below.

Please feel free to get in touch with the office if there is anything we can do to support your research needs during this time.

Enjoy the September edition of your Research Roundup.

Prof Sandra Hodge

Chair, Research Sub-Committee

Call for Abstracts

Abstracts for TSANZSRS21 are now open. Abstracts submitted to the 2020 Annual Scientific Meeting are eligible to resubmit for the 2021 Annual Scientific Meeting. Please note, all resubmitted abstracts will undergo the same robust peer review process for allocation to oral or poster sessions.

Please submit your abstract by 6 November and join us for our first ever virtual ASM in 2021!

 

New Award: CREATE Hope Research Fund PhD Scholarships in Pulmonary Fibrosis

The CREATE PhD Scholarships in Pulmonary Fibrosis will support research into pulmonary fibrosis in Australia

Relevant domains of research inquiry include any form of clinical, population, laboratory, genetic or tissue based research. 

Students who are wishing to undertake a PhD, or are currently enrolled in a PhD in Pulmonary Fibrosis Research, are invited to submit an application. The student must be a resident in Australia throughout the period of the research program.

The Centre of Research Excellence in Pulmonary Fibrosis (the CRE-PF)  will allocate a total of two grants, each of $28,000, for the PhD Scholarships. These scholarships will either fund a stipend for one year for a full time student or may be extended over a second year, should the student be able to secure matching funds to permit extension of the period via their University or Research Institute. Extension of the funding in order to extend the value of the research investment by the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) and Lung Foundation Australia by securing matching funding from the host institution is encouraged and will be regarded favourably.

These funds are to be used for the student stipend. Direct, indirect research costs and/or infrastructure costs do not form part of this grant and will not be covered by this funding.

Click here for more info!

Open Awards

Thoracic Society Awards

TSANZ Past Presidents Scholarship Award – closing 04 October 2020

Boehringer Ingelheim New Zealand Primary Care Grant – closing 04 October 2020

TSANZ ASM 2021 abstract-linked Awards – closing 6 November 2020

 Lung Foundation Awards

Lizotte Family Idiopathic Pulmonary Fibrosis Research Grant – closing 13 October 2020

Ludwig Engel Grant-in-Aid for Physiological Respiratory Research – closing 13 October 2020

Ivan Cash Grant-in-Aid For Idiopathic Pulmonary Fibrosis Research – closing 13 October 2020

Cochrane Airways Australia Scholarship – closing 13 October 2020

Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF)

CREATE Hope Research Fund PhD Scholarships in Pulmonary Fibrosis – closing 31 October 2020

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Respirology – Special Issue and Editor’s Choice
 

Respirology Issue 25.9 September 2020

 

Special Issue: Interventional Pulmonology Pearls

 

Cover caption: A collection of images from the Invited review series International Pumlonology Pearls.

Illustrations credit (A to F clockwise from top left) : A and B: Pyng Lee (personal communication), C and D: Fielding and Oki p.914, E: Guibert et al. p.953, F: Shah and Slebos p.972.

DOI: 10.1111/resp.13598

 

Respirology Issue 25.10 October 2020

 

Acute effects of e-cigarette vaping on pulmonary function and airway inflammation in healthy individuals and in patients with asthma

Serafeim-Chrysovalantis Kotoulas, Athanasia Pataka, Kallipoi Domvri, Dionisios Sypratos, Paraskevi Katsaounou, Konstantinos Porpodis, Evangelia Fouka, Aikaterini Markopoulou, Katalin Passa-Fekte, Ioanna Grigoriou, Theodoros Kontakiotis, Paraskevi Argyropoulou and Despoina Papakosta

 

Cover caption: Asthmatic and healthy smokers underwent pulmonary function tests to assess acute effects of e-cigarettes

DOI: 10.1111/resp.13806

 

Peer Connect Service for people with pulmonary fibrosis in Australia: Participants’ experiences and process evaluation

Gabriella Tikellis, Joanna Y.T. Lee, Tamera J. Corte, Jamie Maloney, Michael Bartlett, Tonia Crawford, Ian N. Glaspole, Nicole Goh, Kelcie Herrmann, Alison J. Hey-Cunningham, Greg Keir, Yet H. Khor, John Price, Debra G. Sandford, Lissa Spencer, Alan Teoh, Jennifer Walsh, Susanne Webster and Anne E. Holland

 

Cover caption:  Bill, diagnosed with IPF in 2015, is a primary peer within the Pulmonary Fibrosis Peer Connect service. (Photograph credit: Lung Foundation Australia)

DOI: 10.1111/resp.13807

Invitations and surveys

BREATHE Study

Do you have asthma, emphysema, chronic bronchitis or bronchiectasis?

Do you live in an area affected by bushfires or bushfire smoke?

If yes to both, you may be eligible for the BREATHE study.

We are studying facemasks for prevention of smoke exposure

Find out more: https://kirby.unsw.edu.au/breathe

Please register your interest: https://www.surveymonkey.com/r/C96DXJN

Contact us: e.kpozehouen@unsw.edu.au

Ethics Approval: HC200477

INVITATION TO PARTICIPATE IN AN ERS STUDY AIMING TO IMPROVE THE QUALITY OF CLINICAL TRIALS EVALUATING THE MANAGEMENT OF COPD EXACERBATIONS

Dear colleagues,

Clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations evaluate heterogeneous outcomes (endpoints), often omitting those that are clinically important and relevant to patients. This limits their usability and comparability.

To remedy this issue, the European Respiratory Society (ERS) set-up a Task Force aiming to develop a core outcome set (COS). A COS is a consensus-based minimum set of clinically important outcomes that should be evaluated in all future clinical trials on the management of COPD exacerbations.

We have identified around 50 outcomes of COPD exacerbations and we need your help to prioritize a small number of the most important outcomes, to be included in the core outcome set and to be evaluated in all future clinical trials on the management of COPD exacerbations. To help us prioritize the outcomes, we will be grateful if you could complete a survey that has two stages, 4-8 weeks apart. Each survey takes about 20 minutes to complete.

In the first survey, you will be asked to rate the importance of 50 outcomes between 1-9:

  • 1-3: Outcomes of limited importance.
  • 4-6: Outcomes that are important but not critical.
  • 7-9: Critical outcomes.

We welcome responses from health professionals, researchers, patients with COPD and any other stakeholders with interest in COPD exacerbations.

In the second survey, you will see a graph summarizing the responses of all participants in the first survey and you will be asked to reconsider your ratings, taking into consideration the views of the other responders. While the aim of this survey will be to reach consensus, you will not have to change your ratings if you do not want to.

Your opinion in both surveys is extremely important in developing the core outcome set.

It is crucial that you complete both surveys and we would be very grateful if you can do this.

Please, take the survey in one of the following languages:

English: https://delphimanager.liv.ac.uk/COPD/
Portuguese: https://delphimanager.liv.ac.uk/COPD-PO/
German: https://delphimanager.liv.ac.uk/COPD-GE/
Hungarian:  https://delphimanager.liv.ac.uk/COPD-HU/
Mandarin: https://delphimanager.liv.ac.uk/COPD-CN/
Spanish: https://delphimanager.liv.ac.uk/COPD-ES/
Russian: https://delphimanager.liv.ac.uk/COPD-RU/
Greek: https://delphimanager.liv.ac.uk/COPD-GR/
Danish: https://delphimanager.liv.ac.uk/COPD-DK/
Italian: https://delphimanager.liv.ac.uk/COPD-IT/

We appreciate this is a difficult time for patients and professionals in the respiratory community. While all efforts should rightly be focused on caring for those affected by the novel coronavirus and COVID-19, we believe that research to improve care and outcomes for respiratory patients is needed now more than ever. We are sensitive to the enormous pressures faced by patients and professionals in our community and will review the timelines for this survey and subsequent work in response to the ongoing global pandemic.

Thank you very much in advance,
Kind regards,
Associate Prof. Jens-Ulrik Jensen,
Dr. Alexander Mathioudakis,
Prof. Jørgen Vestbo,
On behalf of the study team.

 

GLOBAL CURRENT PRACTICES OF MECHANICAL VENTILATION MANAGEMENT IN COVID-19 PATIENTS

Dear Colleague, 

You are invited to partake in the current study, “Global Current Practices of Mechanical Ventilation Management in COVID-19 Patients.” The goal of this study is to explore the current practices of mechanical ventilation support in adult COVID-19 patients worldwide. 

We are carrying out this online survey for frontline clinicians involved in the care of patients with COVID-19, with the aim to examine which ventilation techniques healthcare providers’ used to manage adult COVID-19 patients. It would be helpful if you could complete this survey, the estimated time is 5-10 minutes. While there is limited information available on ventilatory support practices in COVID-19 patients, this international survey will provide further insights into current strengths and limitations of global practices.

Rest assured that your answers will be kept confidential, and no information will be used to identify you or your response. This research project was approved by the Institutional Review Board (IRB), AFHER-IRB-2020-012.

If you have any concern or question regarding this study, please do not hesitate to contact me at Jaber.alqahtani.18@ucl.ac.uk.

THANK YOU!
Jaber Alqahtani
On behalf of the whole international team

 

INVITATION TO PARTICIPATE IN A STUDY ON SELF MANAGEMENT FOR PULMONARY FIBROSIS: WHAT DOES IT MEAN AND HOW MIGHT IT HELP?

Dear Members of the Thoracic Society of Australia and New Zealand, 

Alfred Health and the Centre of Research Excellence in Pulmonary Fibrosis are inviting health professionals involved with pulmonary fibrosis (PF) to take part in a study on self-management for pulmonary fibrosis: what does it mean and how might it help? 

Participation is voluntary and involves you sharing your views, opinions and experiences on the patients’ management of PF through a confidential telephone interview of about 30 minutes in duration

Your perspective is important to help us identify and develop resources that will provide patients with the knowledge and tools to manage their own wellbeing. In turn, this will help health professionals to be better equipped to provide support to people with PF and their families. 

The study has been approved by the Alfred Health Human Ethics Committee (Project number: 144/20). 

If you are interested in participating or would like further information on this study, please contact: 

Professor Anne Holland (Chief Investigator) 
Professor of Physiotherapy, 
Monash University and Alfred Health 
Email: Anne.Holland@monash.edu 
Telephone: (03) 9903 0214 

Ms Joanna Lee (PhD candidate)
Monash University and Alfred Health
Email: joanna.lee2@monash.edu
Mobile: 0431 689 361

Thank you for your time and consideration of our study. 

ASCOT trial

ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.

The trial is conducted on an adaptive platform, results will be continually analysed, so that ineffective therapies can be stopped and new therapies can be evaluated as part of the trial. The trial will be conducted across more than 60 sites in Australia, New Zealand and Asia. The trial is registered at: ACTRN12620000445976, Ethics approval granted through Melbourne Health Human Research Ethics Committee HREC/62646/MH-2020.097

Potential Treatments for COVID-19

There are currently no specific therapies for COVID-19. The two main strategies are to limit the virus replicating (antiviral therapies) or to modulate the immune response (in some severe cases, there is a damaging over exuberant immune response).

ASCOT intends to randomise patients to different therapies to understand their impact on clinical outcomes. We will do this for existing therapies, but also be set-up to test new and emerging therapies as they become available.

ASCOT Trial Intervention

Initially, an open label trial of two existing treatments in a 2×2 factorial design with usual care arm will be conducted.

  1. Lopinavir/ritonavir (kaletra), a combination medicine that is used to treat human immunodeficiency virus-1 (HIV-1) infection
  1. Hydroxychloroquine, a medicine used to treat rheumatoid arthritis and other inflammatory conditions and to prevent and treat malaria.

Protocol documents and further details are available at www.ascot-trial.edu.au

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

 

VOLUME 6.03 – MARCH 2021

VOLUME 4.010 – DECEMBER 2019

Research Roundup:

December 2019

.
 

Welcome Message

As the year draws to a close and many of us are wrapping up for the summer break we have a few short messages for you.

Firstly, we have three awards open which we would like to draw your attention to:

Secondly, late-breaking abstracts are open, so if you have any new work to share with your colleagues, please consider submitting to TSANZSRS 2020!

Lastly, we wish you all a safe and relaxing break over the festive season. For those who will remain at work, we hope all goes smoothly for you! Enjoy the December edition of your research roundup and please check out the surveys below.

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

 

Thoracic Society Awards 

There are three Thoracic Society Awards open:

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Respirology – Editor’s Choice 

Respirology Issue 24.12 December 2019

 

Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD

Mette Reilev, Anton Pottegård, Jesper Lykkegaard, Jens Søndergaard, Truls S Ingebrigtsen and Jesper Hallas

 

 

DOI: 10.1111/resp.13620

Top row, from left to right: Mette Reilev, Jesper Hallas and Anton Pottegård, Clinical Pharmacology and Pharmacy, University of Southern Denmark

Bottom row, from left to right: Jesper Lykkegaard and Jens Søndergaard, The Research Unit for General Practice, University of Southern Denmark

Non-invasive ventilation versus oxygen therapy in cystic fibrosis: A 12-month randomized trial

Maree A. Milross, Amanda J. Piper, Tiffany J. Dwyer, Keith Wong, Scott C. Bell, Peter T.P. Bye and the Non-Invasive Ventilation Cystic Fibrosis (NIVCF) Study Group

Non-invasive ventilation in cystic fibrosis

DOI: 10.1111/resp.13604

Research Project and Survey Requests

 

Competitive Grants of Up To $1 Million To Turn Medical Discoveries Into Clinical Reality (Fed)

Minister for Health, Greg Hunt, says cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

EOI applications open: Tuesday, 15 October 2019.
Closing Date: Monday, 16 December 2019

Click here for further details

Workshops and Conferences

 

Chronic Breathlessness

 

The Australian national Palliative Care Clinical Studies Collaborative (PaCCSC) is pleased to announce the publication of results from a recently completed multi-site, double-blind, randomised controlled trial that found that regular, sustained-release morphine had similar benefits and harms to placebo in this adequately powered trial at one week.

The manuscript is titled “Regular, sustained-release morphine for chronic breathlessness: a multi-centre, double-blind, randomised, placebo controlled trial”. Authored by David Currow and colleagues, the paper was published in Thorax 2019; 213681 (ahead of print). A copy of the paper is attached for your benefit.

 

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 6.03 – MARCH 2021

VOLUME 4.09 NOVEMBER 2019

Research Roundup:

November 2019

.
 

Welcome Message

We are now in the penultimate month of the year, and for the Thoracic Society this sparks the beginning of the busy lead up to our national conference. The Research Sub-committee is in full swing reviewing award applications, the SIG convenors are reviewing abstract submissions, and our conference organisers are ensuring the sessions are programmed smoothly to present your research in the best way possible. For 2020, we are expecting another large conference, having received approximately 440 submissions. Details are gradually being added to the TSANZSRS site and the early program is now visible. Early bird registration is available until the 18th of January, 2020.

Thanks to the many who recently submitted award applications. We would like to highlight that a number of awards are still open and some have been extended – please look below or on our website to find out more information.

We hope you enjoy this edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

 

Thoracic Society Awards 

There are three Thoracic Society Awards open:

 

Lund Foundation Australia Research Awards 

  • Cochrane Airways Australia Scholarship – extended to 15 November 2019

To download application documents, click here.

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

TSANZ Webinar Series

 

“Tracheostomy tubes and principles of management” with Gavin Fahey

Event Date: Thursday, 14th of November 2019

Time: 2:30pm AEDT

Duration: 45 minutes

A presentation covering anatomy and physiology, tube selection, principles of nursing and emergency management.

Only limited places available! Don’t miss out!

The presenter: Gavin Fahey

Gavin Fahey currently works as Senior Respiratory Clinical Nurse Consultant (CNC) at Northern Health (NH) leading a team of Respiratory CNCs who since 2018 have collectively contributed to acquisition and management of oxygen services across NH, development of a 4-bed Respiratory Care Unit caring for patients with severe respiratory failure, and improving lung mass services incorporating development of Victoria’s first Specialist Ambulatory Pleural Service. Gavin’s experience includes working within both the Victorian Respiratory Support Service and Tracheostomy and Management Service (Austin Health) utilising his experience and advanced understanding of tracheostomy and ventilation management within the acute and outpatients setting.

CLICK HERE to register! 

_______________________________________________________________________________

Missed out on a webinar? 

The videos from our previous webinars are now available for on-demand viewing. For more information, please CLICK HERE!

Respirology – Editor’s Choice

Respirology Issue 24.11 November 2019

Nasal high-flow therapy compared with non-invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross-over trial

Steven McKinstry, Joseph Singer, Jan Pieter Baarsma, Mark Weatherall, Richard Beasley, James Fingleton

DOI: 10.1111/resp.13575

Nasal High Flow therapy in use

BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo

Rebecca L. Harper, Suzanne Maiolo, Rebekah J. Ward, Jemma Seyfang, Michaelia P. Cockshell, Claudine S. Bonder, Paul N. Reynolds

Putative mechanism of cell therapy upregulating BMPR2 in pulmonary vessels via release of exosomes

DOI: 10.1111/resp.13552

Research Project and Survey Requests

 

Competitive Grants of Up To $1 Million To Turn Medical Discoveries Into Clinical Reality (Fed)

Minister for Health, Greg Hunt, says cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical devices to improve patient care.

The third round of funding from the Government’s $45 million BioMedTech (MBT) Horizons initiative, funded by our landmark Medical Research Future Fund, will open on 15 October.

EOI applications open: Tuesday, 15 October 2019.
Closing Date: Monday, 16 December 2019

Click here for further details

Workshops and Conferences

Dear TSANZ Members,

Lung Foundation Australia, with the support of nursing members of the Australia and New Zealand – Lung Cancer Nurse Forum, invite you to the next workshop in the series: Treatment Modalities and Management of a Stage 3 NSCLC Patient workshop, in Hobart on Friday 29 November 2019.

These workshops are open to nurses and allied health with an interest in working with and caring for people with lung cancer.

Date: Friday 29 November 2019

Time: 9:30am – 12:30pm

Location: Cancer Support Centre, Royal Hobart Hospital, 48 Liverpool St, Hobart TAS 7000

Program: Medical experts including nurses, medical oncology and radiation oncology specialists, and allied health professionals will discuss the management of a Stage III unresectable lung cancer patient.

More information about the agenda and speakers are coming soon. Please see our website for up to date information on this workshop.

Workshops are free to attend and you will be provided with a certificate for your hours of learning.

Register here

Please RSVP by Friday 22 November 2019. Registrations are essential for seating and catering purposes. For more information on the event, please visit our website here.

For further queries, please contact our information and support centre freecall on 1800 654 301 or email enquiries@lungfoundation.com.au.

We hope to see you on the day!

Kind Regards,

Lung Foundation Australia

 

                                                                                                                                                              

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

VOLUME 6.03 – MARCH 2021

VOLUME 4.07 SEPEMBER 2019

Research Roundup:

September 2019

.
 

Welcome Message

Welcome to the September Issue. Many of our current TSANZ Awards will be closing next month, following the Abstract Submission deadline for our TSANZSRS2020 ASM. Preparations are well and truly underway for the ASM so we hope to see you there and presenting your work!

If you are interested in attending the APSR Congress in November, we have one LFA A/Menarini Travel Award closing on 13 September to sponsor those researching or involved in COPD.

Submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. If you have been trying to uncover some hidden academic riches locked away in the recesses of respiratory research, we want to hear about it! You will be featured in an upcoming Research Roundup and also published on the limbic website. This is a great opportunity to tell us about your research and inspiration, and provides a platform to be able to connect your passion project with our network of TSANZ members and the limbic subscribers. Details can be found here.

Lastly, please support the research of TSANZ members and supporters by contributing to the surveys at the end of this newsletter.

We hope you enjoy this edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ ASM 2020 abstract-linked Awards – closing 11 October 2019

TSANZ Indigenous Respiratory Nursing Award – closes 30th October 2019

TSANZ Peter Phelan Research Award – closes 30th October 2019

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 30th October 2019

Lung Foundation Awards

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards APSR closing 13th September 2019 (5pm AEST)

Lung Foundation Australia / Brian Eaton PhD IPF Scholarship 2019EXTENDED closing date 30 October 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Respirology – Editor’s Choice 

Respirology Issue 24.9 September 2019

Special Issue on Pulmonary Fibrosis Awareness Month

 

In support of Pulmonary Fibrosis Awareness month September, Respirology offers free access to selected articles during the month of September 2019.
The articles will be available at
https://onlinelibrary.wiley.com/page/journal/14401843/pf-awareness-month-2019

Research Project and Survey Requests

Dear TSANZ Members,

You are invited to participate in a survey that is being conducted as part of a research study. The following survey asks a series of questions about your current practice in regards to Advance Care Planning in patients with chronic obstructive pulmonary disease (COPD). 

This study is being conducted by:
Ms Mary Roberts, Dr Tracy Smith, Professor Wheatley and Dr Jin-Gun Cho. Details and affiliations of the research team can be obtained by contacting Ms Mary Roberts by phone 0408 490 371 or email mary.roberts@health.nsw.gov.au

The results of the survey will form part of a research project with the aim to develop resources to improve the quality and uptake of advanced care planning in patients with COPD. This survey has been approved by the WSLHD HREC under authorisation number 5990 2019/ETH00197.

The estimated time to complete the survey is 10-15 minutes. If you exit out the survey early or don’t click DONE on the final page, your responses will not be saved. You may skip questions if you wish, though we would prefer you didn’t.  

Your participation is voluntary and anonymous. Your contribution is greatly appreciated.
We thank you in advance for your participation.
Here is the link: https://www.surveymonkey.com/r/8S6TLF6

Sincerely,

Ms MM Roberts

Mary Roberts

Clinical Nurse Consultant | Respiratory Ambulatory Care

Clinical Lecturer, Sydney Medical School, University of Sydney

 

Determining a Patient-Centred Model of Care in Severe Asthma: What can we learn from the views, needs, and challenges of Clinicians’ and Carers of people with Severe Asthma and COPD?

Phase 1- Clinicians’ group

Investigators: Dr Vanessa Clark, Professor Vanessa McDonald, Professor Peter Gibson, and Eleanor Majellano

Invitation

You are invited to participate in a research study that explores the barriers and facilitators to the optimal management of severe asthma. This research is being conducted as part of the requirements for a PhD at the University of Newcastle by Eleanor Majellano, under the supervision of Professor Vanessa McDonald and Dr Vanessa Clark. We are investigating the barriers, facilitators and attitudes of clinicians and allied healthcare professionals towards the optimal management of severe asthma in various healthcare settings.

Before you decide whether or not you wish to participate in this study, it is important for you to understand why the research is being conducted and what it will involve.

Please download the information and participation forms here if you are interested or would like to contact the investigators:

Participation Information Sheet.

This study has been approved by the Hunter New England Human Research Ethics Committee Reference. If you have concerns or complaints about the conduct of this study you should contact:

Dr. Nicole Gerrand

Manager

Research Ethics & Governance Office

Hunter New England Local Health District

   Email: HNELHD-HREC@health.nsw.gov.au

The manager is the person nominated to receive complaints from research participants.

You will need to quote reference number 2019/ETH00143.

 

Thank you for taking the time to consider this study.

If you wish to take part in it, please sign the attached consent form.

This information sheet is for you to keep.

 

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

VOLUME 6.03 – MARCH 2021

VOLUME 4.06 AUGUST 2019

Research Roundup:

August 2019

.
 

Welcome Message

We received some exciting news with the announcement that the National Dust Disease Taskforce has been established by the Australian Government Department of Health. TSANZ and its members will play a key role in the Taskforce, enabling us to further contribute to the work we have been doing around preventable occupational lung disease.

Don’t forget to visit our TSANZSRS2020 website for more details about abstracts & TSANZ Travel Awards, and keep in mind the closing date of October 11th. Our Open Awards section below highlights our ongoing awards, grants and scholarships from the Lung Foundation Australia.

Submissions are always open for our “Research Roundup Holy Grail,” supported by the limbic. Details can be found here. Our most recent submission by Dr Jane Bourke is featured in this month’s the limbic section below.

We hope you enjoy the August edition of your Research Roundup!

Prof Sandra Hodge

Chair, Research Sub-Committee

Open Awards

Thoracic Society Awards

TSANZ ASM 2020 abstract-linked Awards – closing 11 October 2019
(N.B. the submission portal will become live on July 12)

TSANZ Indigenous Respiratory Nursing Award – closes 30th October 2019

TSANZ Peter Phelan Research Award – closes 30th October 2019

TSANZ Rob Pierce Grant-in-Aid for Indigenous Lung Health – closes 30th October 2019

Lung Foundation Awards

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards APSR closing 13th September 2019 (5pm AEST)

BI / COPD Research Fellowship – closes 25 August 2019

Lung Foundation Australia / Lizotte Family Research Award for IPF Research – closes 25 August 2019

LFA / Ludwig Engel Grant-In-Aid for Physiological Research – closes 25 August 2019

Ivan Cash Grant-In-Aid for IPF Research – closes 25 August 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

Respirology – Editor’s Choice

Respirology Issue 24.8 August 2019

Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score‐matched analysis

Hironao Hozumi, Hirotsugu Hasegawa, Koichi Miyashita, Hideki Yasui, Yuzo Suzuki, Masato Kono, Masato Karayama, Kazuki Furuhasi, Dai Hashimoto, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Yutaro Nakamura, Koshi Yokomura, Hidenori Nakamura, Takafumi Suda

Researchers from Hamamatsu University School of Medicine, Hamamatsu, Japan. From left to right: Prof. Takafumi Suda and Dr. Hironao Hozumi

DOI: 10.1111/resp.13506

 

Epithelial cell adhesion molecule (EpCAM) from pleural fluid cell lysates is a highly accurate diagnostic biomarker of adenocarcinomatous effusions

Jose M. Porcel, Aureli Esquerda, Silvia Biesla, Anna Novell, Maria Alba Sorolla, Sonia Gatius, Carlos Zamora, Silvia Vidal, Antonieta Salud

 

The pleural research team at IRBLleida in Spain. From left to right: Drs Sorolla, Salud, Bielsa, Novell, Esquerda (behind) and Porcel.

DOI: 10.1111/resp.13539

Research Project and Survey Requests

 

What is “suspected” lung cancer?

Lung cancer is the leading cause of cancer-related mortality and morbidity in Australia. The Cancer Council’s Optimal Care Pathway suggests that patients with suspected lung cancer on CT scan be seen by a specialist within two weeks. But what exactly is “suspected” lung cancer? Does that 5mm lung nodule found incidentally on CT coronary angiogram need urgent specialist attention?

St John of God Healthcare doctors and Curtin University researchers are inviting respiratory physicians to help us define “suspected” lung cancer. We need you to review 10 short case scenarios and tell us if each of the patients should be seen by a specialist within two weeks.

To participate, click here.

You have been anonymously invited to participate because the Thoracic Society of Australia and New Zealand identifies you as a member. Consent is implied by your voluntary participation. This research study has been reviewed and given approval from the Curtin University and St John of God Healthcare Human Research Ethics Committees.
If you have questions or comments, you can contact the Principle Investigator on david.manners@sjog.org.au, the Curtin University HREC on hrec@curtin.edu.au or the SJOG Healthcare HREC on ethics@sjog.org.au.

 

Can you help TSANZ make a difference?

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt.
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

VOLUME 6.03 – MARCH 2021

VOLUME 4.05 JULY 2019

Research Roundup:

July 2019

.
 

Welcome Message

Welcome to another edition of our TSANZ Research Roundup. The wheels have officially begun turning for our 2020 TSANZ ASM, which means a wide range of opportunities to submit abstracts and will be opening on 12 July! Please visit our TSANZSRS2020 website for more details about abstracts & TSANZ Travel Awards once the submission portal is live, and pay close attention to the closing dates.
For our registered nurses, don’t forget about the TSANZ Indigenous Respiratory Nursing Awards, which will help support the cost of attendance to the TSANZ ASM for those with indigenous heritage, or working with indigenous communities in respiratory health.

We have a few new Lung Foundation Australia awards opening this month, so see below for details. Applications are still open for LFA/A Menarini travel grants for ERS and APSR – if you are interested in attending be sure to send in your submissions before the deadline. We have also extended the date for the Brian Eaton IPF award.
If you are planning on attending the TSANZ New Zealand Annual Scientific Meeting, we still have travel grant applications open until 15 July so click here to apply now.

We would also like to bring to your attention the Bupa 2019 Emerging Health Researcher Awardnominations are open on their website. This award is designed for Early Career Researchers and the recipient will receive a prize of $25,000 to put towards further research. Selected Finalists and Highly Commended nominations will also be recognised.
icare also have opened their Dust Diseases Grant program to applicants, which closes 2 August. Please scroll down for more information on both.

We hope you enjoy the July edition of your Research Roundup!

 

Tanya Buchanan
(standing in for Sandra Hodge earning a well-earned break!)
CEO, The Thoracic Society of Australia and New Zealand

Open Awards

Thoracic Society Awards

TSANZ NZ ASM Travel Grants 2019 – closes 15th July 2019

TSANZ ASM 2020 abstract-linked Awards – closing 11 October 2019
(N.B. the submission portal will become live on July 12)

TSANZ Indigenous Respiratory Nursing Award – closes 30th October 2019

Lung Foundation Awards

LFA / Brian Eaton IPF PhD Scholarship – EXTENDED until 14 July 2019 

Lung Foundation Australia / A Menarini Pty Ltd 2019 Travel Awards 

Travel application deadlines

ERS: 31st July 2019 (5pm AEST)

APSR: 13th September 2019 (5pm AEST)

N.B. The following awards will open 14 July

BI / COPD Research Fellowship – closes 25 August 2019

Lung Foundation Australia / Lizotte Family Research Award for IPF Research – closes 25 August 2019

LFA / Ludwig Engel Grant-In-Aid for Physiological Research – closes 25 August 2019

Ivan Cash Grant-In-Aid for IPF Research – closes 25 August 2019

 

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements…

iCare Dust Diseases Grant Program

For all the application details, please visit https://www.icare.nsw.gov.au/injured-or-ill-people/work-related-dust-disease/research-and-funding/#gref.
If you have any questions or would like to know more about the program please contact: ddcgrants@icare.nsw.gov.au 

Bupa Health Foundation Emerging Health Researcher Award

The Bupa Health Foundation is seeking nominations for its 2019 Emerging Health Researcher Award.  

Nominations close on Monday 15th July 2019 (9AM AEST).

Award criteria and the nomination form can be found at https://www.bupa.com.au/about-us/bupa-health-foundation.

Should you have any queries, please contact Alana Fisher, Operations Manager, Bupa Health Foundation at foundation@bupa.com.au

_______________________________________________________________________________

Respirology – Editor’s Choice 

Respirology Issue 24.7 July 2019

Clinical usefulness of routine AFB culture and MTB PCR of EBUS‐TBNA needle rinse fluid

Ryoung-Eun Ko, Byeong-Ho Jeong, Hae Ri Chon, Hee Jae Huh, Joungho Han, Hyun Lee, Kyungjong Lee, Hojoong Kim, O. Jung Kwon, Sang-Won Um

 

Researchers from the Division of Pulmonary and Critical Care Medicine at the Samsung Medical Center in Seoul, South Korea. From left to right: Byoung-Ho Jeong, Sang-Won Um, and Ryoung-Eun Ko

DOI: 10.1111/resp.13488

 

Changes in physical activity during hospital admission for chronic respiratory disease

Mark W. Orme, Theresa C. Harvey-Dunstan, Ismet Boral, Emma J.L. Chaplin, S. Fayyaz Hussain, Mike D.L. Morgan, Michael C. Steiner, Sally J. Singh, Neil J. Greening

 

A single day of physical activity monitoring

DOI: 10.1111/resp.13513

Research Project and Survey Requests

 

What is “suspected” lung cancer?

Lung cancer is the leading cause of cancer-related mortality and morbidity in Australia. The Cancer Council’s Optimal Care Pathway suggests that patients with suspected lung cancer on CT scan be seen by a specialist within two weeks. But what exactly is “suspected” lung cancer? Does that 5mm lung nodule found incidentally on CT coronary angiogram need urgent specialist attention?

St John of God Healthcare doctors and Curtin University researchers are inviting respiratory physicians to help us define “suspected” lung cancer. We need you to review 10 short case scenarios and tell us if each of the patients should be seen by a specialist within two weeks.

To participate, click here.

You have been anonymously invited to participate because the Thoracic Society of Australia and New Zealand identifies you as a member. Consent is implied by your voluntary participation. This research study has been reviewed and given approval from the Curtin University and St John of God Healthcare Human Research Ethics Committees.
If you have questions or comments, you can contact the Principle Investigator on david.manners@sjog.org.au, the Curtin University HREC on hrec@curtin.edu.au or the SJOG Healthcare HREC on ethics@sjog.org.au.

 

Survey of Attitudes of Australian Specialists to Lung Cancer Screening with Low Dose Computed Tomography

To Members of the Thoracic Society of Australia and New Zealand,

Lung cancer screening with low dose computed tomography has been implemented overseas however is still a debated topic within Australia. We are conducting a survey of Australian specialists and their knowledge and attitudes towards lung cancer screening and perceived barriers to the implementation of lung cancer screening with low dose computed tomography within Australia.

The anonymous survey is available online using the SurveyMonkey survey tool and takes approximately 7 minutes to complete.  It can be accessed via the following link.  https://www.surveymonkey.com/r/AttitudesToLDCT

Please don’t hesitate to contact us if you require any further information.  We attach our study protocol and copy of HREC approval (The Prince Charles Hospital Human Research and Ethics Committee LNR/2018/QPCH/44970).

Thank you for your kind support.

Yours truly

Rachel McLellan, Advanced RACP Trainee
Kwun Fong
Henry Marshall
Rayleen Bowman
Ian Yang

University of Queensland Thoracic Research Centre at The Prince Charles Hospital
Metro North Hospital and Health Service | Queensland Government
Rode Road, Chermside, Brisbane QLD 4032, AUSTRALIA
t. 61 7 [31394000] e. ILST@health.qld.gov.au | www.health.qld.gov.au

 

 

New survey about Victorian doctors’ end-of-life decision-making

Victorian doctors in specialties likely to be involved in end-of-life decisions are being surveyed about their decision-making practices involving adult patients. Researchers from the NHMRC-funded Centre of Research Excellence in End-of-Life Care are conducting a study to determine what sort of end-of-life decisions are being made by doctors, how often these decisions occur and for what sort of patients.

At present, there are no up-to-date, representative Australian data describing the frequency and nature of medical end-of-life decisions involving adults, and the characteristics of patients about whom such decisions are made. The research aims to provide an evidence base to understand current medical practice in Victoria including the extent to which palliative care is provided to patients at the end of life. Findings from this research will also inform improvements in the quality of end-of-life care.

A sample of Victorian doctors will be contacted in April and May by the AMA’s Australia Medical Publishing Company (AMPCo) to invite them to complete a survey.  The survey can be completed in hard copy or online.  Participating doctors who complete their survey before 16 May will go into the draw for one of three prizes to the value $100, in fine wine, or a donation to a registered charity of your choice.

If you have any queries about this research, please feel free to contact Dr Rachel Feeney[rachel.feeney@qut.edu.au]. The research team is grateful for the time and insight of the doctors who support this research by completing this survey.

 

 

Genomic medicine here to stay? Have your say.

Are you a medical specialist in Australia?

If so, tell us your thoughts about genomic medicine
practice and continuing medical education!

We need to hear from non-genetic medical specialists
who work clinically in Australia.

We want to know about past, present and future aspects
of genetics and health, including genomics in healthcare.

It doesn’t matter how much you know about this,
or whether you incorporate genomics into your practice or not;
your opinions, views and experiences are valuable to us.

You will help shape future workforce practices and
continuing education and training programs

Click here to complete the anonymous 15-minute survey.
Please distribute this link to your networks

Please note there are separate studies for clinical geneticists, oncologists, pathologists, radiologists and general practitioners, who will be contacted directly.

This survey is an activity of the Workforce Development Program of the NH&MRC-funded
Australian Genomics Health Alliance. If you have any queries, please contact Dr Amy Nisselle, Specialist Project Officer, Australian Genomics Health Alliance (amy.nisselle@mcri.edu.au or 03 9936 6340).

This survey has HREC approval, The University of Melbourne (1646785.8).

Can you help TSANZ make a difference?
 

Your support makes a difference, and helps us continue to provide funding for research and our TSANZ awards. If you would like to support our work, you can leave a tax deductible donation of your choice in our areas of need.

1. Making a donation to our Benevolent Fund

The Benevolent Fund supports projects aimed at improving the respiratory health care of individuals who are in a setting where health care resources and delivery are poor.
CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

2. Making a donation to support research

With your support, we can continue to support Australia and New Zealand’s most significant and cutting edge respiratory health research, and benefit Australians and New Zealanders suffering from lung disease.
Please CLICK HERE to make a donation or by filling out the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au.

3. Establishing a named award

For significant donations of above $10,000 AUD, a TSANZ award can be established in your name. Please call the TSANZ office on +61 2 9222 6200.

4. Leave TSANZ a gift in your will

If you are interested in supporting TSANZ in the future, one way to do so is to leave TSANZ a gift in your will. Any support is greatly appreciated and will leave a lasting legacy.
If interested, please notify us by ticking the box on the Support TSANZ form. Once you have completed the form, please email TSANZOffice@thoracic.org.au. Alternatively, please call the TSANZ Office on +61 2 9222 6200.

5. TSANZ New Zealand Branch Incorporated 

New Zealand members are reminded that you are also able to make a tax deductible donation directly to the NZ branch. You can assist the NZ branch to provide services to members across NZ. If you make a payment via electronic funds transfer (EFT), please notify the TSANZ office so that we can arrange a receipt. 
CLICK HERE to make a donation.

Thank you for your continued support of TSANZ

.

WHY JOIN US?

Become part of a network of professionals working in respiratory and lung health clinical care and treatment, research, health promotion and advocacy.

By browsing our website you agree to our use of cookies outlined in our revised Privacy Policy and Terms & Conditions.

X